Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
32.42
+0.60 (1.89%)
At close: Jan 17, 2025, 4:00 PM
30.10
-2.32 (-7.16%)
Pre-market: Jan 21, 2025, 4:07 AM EST
Agios Pharmaceuticals Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for AGIO stock have an average target of 56.33, with a low estimate of 46 and a high estimate of 75. The average target predicts an increase of 73.75% from the current stock price of 32.42.
Analyst Consensus: Buy
* Price targets were last updated on Dec 10, 2024.
Analyst Ratings
The average analyst rating for AGIO stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 2 | 2 | 4 | 4 | 4 | 4 |
| Hold | 2 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Dec 18, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $55 → $57 | Buy | Maintains | $55 → $57 | +75.82% | Dec 10, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $53 → $75 | Buy | Maintains | $53 → $75 | +131.34% | Dec 9, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $55 | Buy | Reiterates | $55 | +69.65% | Nov 1, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $51 → $53 | Buy | Maintains | $51 → $53 | +63.48% | Nov 1, 2024 |
Financial Forecast
Revenue This Year
35.79M
from 26.82M
Increased by 33.41%
Revenue Next Year
97.39M
from 35.79M
Increased by 172.14%
EPS This Year
11.71
from -6.33
EPS Next Year
-6.25
from 11.71
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 38.5M | 281.1M | 250.3M | |||
| Avg | 35.8M | 97.4M | 193.0M | |||
| Low | 33.3M | 51.0M | 143.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 43.7% | 685.5% | 157.0% | |||
| Avg | 33.4% | 172.1% | 98.2% | |||
| Low | 24.2% | 42.4% | 47.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 12.44 | -3.38 | -3.42 | |||
| Avg | 11.71 | -6.25 | -5.17 | |||
| Low | 10.27 | -7.06 | -7.10 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.